Westside Investment Management, Inc.

Holdings History for Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB)

Symbol: INMB on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.03%	+0%	$169,962	108,950	+5,500	+5.3%	$1.56	Q4 2025
30 Sep 2025	0.03%	+0.03%	$214,150	103,450	+82,075	+384%	$2.07	Q3 2025
30 Jun 2025	0.01%	-0.03%	$49,379	21,375	-67,825	-76%	$2.31	Q2 2025
31 Mar 2025	0.15%	-0%	$696,660	89,200	-775		$7.81	Q1 2025
31 Dec 2024	0.09%	+0.02%	$420,191	89,975	+18,660	+26%	$4.67	Q4 2024
30 Sep 2024	0.08%	+0.03%	$384,397	71,315	+25,975	+57%	$5.39	Q3 2024
30 Jun 2024	0.09%	+0.02%	$399,903	45,340	+10,950	+32%	$8.82	Q2 2024
31 Mar 2024	0.1%	-0.02%	$404,084	34,390	-7,475	-18%	$11.75	Q1 2024
31 Dec 2023	0.12%	+0%	$471,404	41,865	+325	+0.78%	$11.26	Q4 2023
30 Sep 2023	0.08%	-0%	$281,227	41,540	-700	-1.7%	$6.77	Q3 2023
30 Jun 2023	0.11%	+0.01%	$383,539	42,240	+5,135	+14%	$9.08	Q2 2023
31 Mar 2023	0.07%	+0.01%	$239,703	37,105	+6,715	+22%	$6.46	Q1 2023
31 Dec 2022	0%	+0%	$192,000	30,390	+150	+0.5%	$6.32	Q4 2022
30 Sep 2022	0%	+0%	$187,000	30,240	+100	+0.33%	$6.18	Q3 2022
30 Jun 2022	0%	+0%	$266,000	30,140	+3,750	+14%	$8.83	Q2 2022
31 Mar 2022	0%	+0%	$222,000	26,390	+18,590	+238%	$8.41	Q1 2022
31 Dec 2021	0%	+0%	$79,000	7,800	+7,800	NEW	$10.13	Q4 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.